Cargando…

Screening for hepatocellular carcinoma: What is missing?

While there are guidelines from all major liver societies for the screening and management of hepatocellular carcinoma (HCC), many issues remain surrounding the actual practice of screening. This review discusses how to diagnose and screen HCC and more importantly, how well we diagnose and screen fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehta, Neil J., Celik, Aygul Dogan, Peters, Marion G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747036/ https://www.ncbi.nlm.nih.gov/pubmed/29404430 http://dx.doi.org/10.1002/hep4.1014

Ejemplares similares

Hepatocellular Carcinoma—How to Determine Therapeutic Options
por: Mehta, Neil
Publicado: (2020)

Screening for Hepatocellular Carcinoma
por: Lui, Hock-Foong
Publicado: (2011)

From salt to hypertension, what is missed?
por: Ma, Zhiyi, et al.
Publicado: (2021)

Hepcidin in hepatocellular carcinoma
por: Joachim, Jonathan H., et al.
Publicado: (2022)

Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations
por: Zelber-Sagi, Shira, et al.
Publicado: (2021)

Radioembolization for hepatocellular carcinoma: what clinicians need to know
por: Choi, Jin Woo, et al.
Publicado: (2022)

Screening for hepatocellular carcinoma: patient selection and perspectives
por: Fateen, Waleed, et al.
Publicado: (2017)

Screening for Hepatocellular Carcinoma in Patients with Hepatitis B
por: Sachar, Yashasavi, et al.
Publicado: (2021)

What’s missing in autism spectrum disorder motor assessments?
por: Wilson, Rujuta B., et al.
Publicado: (2018)

Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic
por: Mehta, Neil, et al.
Publicado: (2021)

Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?
por: Li, Xiaoming, et al.
Publicado: (2022)

Plant Mitophagy in Comparison to Mammals: What Is Still Missing?
por: Ren, Kaike, et al.
Publicado: (2021)

Beyond Rheumatoid Arthritis Evaluation: What are We Missing?
por: Espinoza, Gianna, et al.
Publicado: (2021)

Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update
por: Lok, James, et al.
Publicado: (2021)

Targeting Hepatocellular Carcinoma: What did we Discover so Far?
por: Brito, Ana Filipa, et al.
Publicado: (2016)

Eosinopenia in COVID-19: What we missed so far?
por: Davido, Benjamin, et al.
Publicado: (2021)

Neopterin, Inflammation, and Oxidative Stress: What Could We Be Missing?
por: Gieseg, Steven P., et al.
Publicado: (2018)

Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?
por: Lucarelli, Enrico, et al.
Publicado: (2023)

Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review
por: Ruggeri, Matteo
Publicado: (2012)

What are the missing pieces needed to stop antibiotic resistance?
por: Martínez, José L., et al.
Publicado: (2023)

Molecular Pathology of ALS: What We Currently Know and What Important Information Is Still Missing
por: Jankovska, Nikol, et al.
Publicado: (2021)

Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?
por: Seinstra, Beatrijs A., et al.
Publicado: (2010)

What’s missing in geographical parsing?
por: Gritta, Milan, et al.
Publicado: (2017)

In vitro embryo production in small ruminants: what is still missing?
por: Souza-Fabjan, Joanna Maria Gonçalves, et al.
Publicado: (2023)

Hepatocellular carcinoma among cirrhotics - Utility of screening and surveillance programs - Review article -
por: Opriță, R, et al.
Publicado: (2014)

What is the difference between missing completely at random and missing at random?
por: Bhaskaran, Krishnan, et al.
Publicado: (2014)

Structural biology of the intrinsic cell death pathway: what do we know and what is missing?
por: Lee, Erinna F., et al.
Publicado: (2012)

Pediatric Hepatocellular Adenomas: What Is Known and What Is New?
por: Espinoza, Andres F., et al.
Publicado: (2023)

An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma
por: Wong, Robert J., et al.
Publicado: (2022)

Evaluating the Effectiveness of Interventions on Increasing Participation in Cervical Cancer Screening
por: KURT, Gonul, et al.
Publicado: (2019)

The Immune Mechanisms of Severe Equine Asthma—Current Understanding and What Is Missing
por: Simões, Joana, et al.
Publicado: (2022)

Status of Metabolomic Measurement for Insights in Alzheimer’s Disease Progression—What Is Missing?
por: Yin, Chunyuan, et al.
Publicado: (2023)

Treatment of Cardiac Fibrosis with Extracellular Vesicles: What Is Missing for Clinical Translation?
por: Neuber, Sebastian, et al.
Publicado: (2023)

Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know
por: Baj, Jacek, et al.
Publicado: (2022)

Biomarkers for hepatocellular carcinoma: What’s new on the horizon?
por: Ocker, Matthias
Publicado: (2018)

Preparation and Characterization of Crayfish (Astacus leptodactylus) Chitosan with Different Deacetylation Degrees
por: Kadak, Ali Eslem, et al.
Publicado: (2023)

Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?
por: Lee, Hye Won, et al.
Publicado: (2020)

Evaluation of structural changes in orbitofrontal cortex in relation to medication overuse in migraine patients: a diffusion tensor imaging study
por: Tantik Pak, Aygul, et al.
Publicado: (2021)

Anesthesiologists and burnout: what are we missing?
por: Bansal, Priyanka, et al.
Publicado: (2021)

What’s missing from a note
por: Santhanam, Divya
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rs4qbpohfr30ij2f67eh6dmga9